Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VIGABATRIN USP, with a corresponding US DMF Number 31953.
Remarkably, this DMF maintains an Active status since its submission on July 29, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 15, 2017, and payment made on August 23, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II